TSX: PMN

TORONTO, March 18, 2016 /CNW/ – ProMIS Neurosciences (“ProMIS” or the “Company”) today announced that, following the identification of its first two targets announced on November 12, 2015 and February 3, 2016, it has identified a third in a series of novel potential…